The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study

Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium

(2019) David C Muller et al.   BMJ-British Medical Journal

C-reactive protein concentration and risk of selected obesity-related cancers in the Women’s Health Initiative

(2018) Theodore M. Brasky et al.   CANCER CAUSES & CONTROL

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

(2018) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

(2017) Paul M Ridker et al.   LANCET

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardio-oncology Related to Heart Failure

(2017) Anne Blaes et al.   Heart Failure Clinics

From C-Reactive Protein to Interleukin-6 to Interleukin-1

(2016) Paul M Ridker   CIRCULATION RESEARCH

Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population

(2016) Kristine H. Allin et al.   INTERNATIONAL JOURNAL OF CANCER

Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study

(2015) Monika Izano et al.   INTERNATIONAL JOURNAL OF CANCER

C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis

(2014) Bo Zhou et al.   CANCER CAUSES & CONTROL

A Prospective Follow-up Study of the Relationship between C-Reactive Protein and Human Cancer Risk in the Chinese Kailuan Female Cohort

(2014) G. Wang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study

(2013) Anna E. Prizment et al.   CANCER CAUSES & CONTROL

Cancer Risk in Patients with Manifest Vascular Disease: Effects of Smoking, Obesity, and Metabolic Syndrome

(2013) R. C. M. van Kruijsdijk et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study

(2010) Kristine H. Allin et al.   JNCI-Journal of the National Cancer Institute

Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer

(2009) Kristine H. Allin et al.   JOURNAL OF CLINICAL ONCOLOGY

Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis

(2008) Katriina Heikkilä et al.   CANCER CAUSES & CONTROL

Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study

(2008) R. J. Glynn et al.   CLINICAL CHEMISTRY